Harte-Hanks Return on Equity

Harte-Hanks (HHS) currently reports a ROE of -37.23%. That is below the Consumer Discretionary sector average of 23.23%. Use the charts on this page to explore Harte-Hanks's ROE history and peer comparisons.

Harte-Hanks's ROE of -37.23% is lower than the Consumer Discretionary sector average of 23.23%. That is roughly 260.3% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Harte-Hanks's current -37.23% should be judged against Consumer Discretionary norms (sector average: 23.23%) and against HHS's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of -37.23%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Consumer Discretionary average is 23.23%. From there, open related valuation or income-statement pages for Harte-Hanks, and consider following HHS for alerts when major investors trade the stock.

Harte-Hanks is classified in the Consumer Discretionary sector. On ROE, it currently shows -37.23% versus a sector average near 23.23%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Consumer Discretionary are usually more informative than comparing HHS with unrelated industries.